Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): CDC Grants for Public Health Research Dissertation, Panel F, Funding Opportunity Announcement (FOA) PAR07-231, 12134 [E9-6216]
Download as PDF
12134
Federal Register / Vol. 74, No. 54 / Monday, March 23, 2009 / Notices
such as their age and time in the mining
industry. Additional data will then be
collected at 1, 3, and 6 months after the
study commences. The mine workers
will be asked to provide their feedback
regarding factors such as body part
discomfort, usability, durability, and
ease of movement.
There will be no cost to the
respondents.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden
per response
(in hours)
Number of
responses per
respondent
Number of
respondents
Respondents
Section Foreman (pilot mine) ..........................................................................
Mine Workers (pilot mine—baseline) ...............................................................
Mine Workers (pilot mine—one month) ...........................................................
Mine Workers (pilot mine—focus group) .........................................................
Section Foreman (full study) ............................................................................
Mine Workers (full study—baseline) ................................................................
Mine Workers (full study—1, 3, and 6 months for control and prototypes) ....
1
9
9
9
6
54
54
1
1
1
1
12
1
6
10/60
20/60
30/60
1
10/60
20/60
25/60
Total ..........................................................................................................
........................
........................
........................
Dated: March 11, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–6214 Filed 3–20–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 16, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–6216 Filed 3–20–09; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): CDC Grants for
Public Health Research Dissertation,
Panel F, Funding Opportunity
Announcement (FOA) PAR07–231
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
dwashington3 on PROD1PC60 with NOTICES
Total burden
(in hours)
Time and Date: 2 p.m.–5 p.m., May 12,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘CDC Grants for Public Health
Research Dissertation, Panel F, FOA PAR07–
231.’’
For Further Information Contact: Susan B.
Stanton, D.D.S., Scientific Review Officer,
Office of the Director, Office of the Chief
Science Officer, CDC, 1600 Clifton Road, NE.,
Mailstop D74, Atlanta, GA 30333, Telephone:
(404) 639–4640.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
VerDate Nov<24>2008
15:28 Mar 20, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
0.5
3
4.5
9
12
18
135
182
Atlanta, GA 30333, Telephone (404) 498–
1194.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 6, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–6220 Filed 3–20–09; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Acceptability,
Feasibility and Validity of Genital SelfSampling for HPV Among Men, PEP
2009–R–01
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 10 a.m.–12 p.m., May 18,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Acceptability, Feasibility and
Validity of Genital Self-Sampling for HPV
Among Men, PEP 2009–R–01.’’
Contact Person for More Information:
Linda Shelton, Public Health Analyst,
Coordinating Center for Health and
Information Service, Office of the Director,
CDC, 1600 Clifton Road, NE., Mailstop E21,
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and Control Initial Review Group
(NCIPC, IRG)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting:
Times and Date: 1 p.m.–1:30 p.m., April
30, 2009 (Open). 1:30 p.m.–6 p.m., April 30,
2009 (Closed).
Place: Teleconference, Toll Free: 888–793–
2154, Participant Passcode: 4424802, CDC,
Chamblee Campus, Building 106, 4770
Buford Highway, Atlanta, GA 30341.
Status: Portions of the meetings will be
closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and
(6), Title 5, U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Section
10(d) of Public Law 92–463.
Purpose: This group is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
E:\FR\FM\23MRN1.SGM
23MRN1
Agencies
[Federal Register Volume 74, Number 54 (Monday, March 23, 2009)]
[Notices]
[Page 12134]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-6216]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): CDC Grants for Public Health Research
Dissertation, Panel F, Funding Opportunity Announcement (FOA) PAR07-231
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time and Date: 2 p.m.-5 p.m., May 12, 2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to
``CDC Grants for Public Health Research Dissertation, Panel F, FOA
PAR07-231.''
For Further Information Contact: Susan B. Stanton, D.D.S.,
Scientific Review Officer, Office of the Director, Office of the
Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D74,
Atlanta, GA 30333, Telephone: (404) 639-4640.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: March 16, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-6216 Filed 3-20-09; 8:45 am]
BILLING CODE 4163-18-P